Milestone Pharmaceuticals Inc.
MIST
$1.51
-$0.13-7.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -40.82% | -26.31% | -38.48% | -100.51% | 9.17% |
| Total Depreciation and Amortization | 8.47% | 0.00% | 7.69% | -3.57% | 6.58% |
| Total Amortization of Deferred Charges | 18.56% | 14.74% | 16.48% | 17.24% | 15.48% |
| Total Other Non-Cash Items | 134.64% | 0.76% | 4.26% | -4.58% | -20.57% |
| Change in Net Operating Assets | -98.04% | -133.17% | -267.29% | 609.12% | 182.86% |
| Cash from Operations | -86.69% | -38.90% | -107.60% | -56.17% | 30.14% |
| Capital Expenditure | -1,186.36% | 50.00% | -57.14% | -- | 29.03% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -84.57% | -639.43% | 4.91% | 224.34% | 41.21% |
| Cash from Investing | -86.02% | -639.79% | 4.87% | 224.32% | 41.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 151,704.17% | 62,528.38% | -- | -99.49% | 2,300.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 151,704.17% | 66,005.41% | 112.08% | -99.57% | 2,300.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 110.64% | 1,004.10% | -182.59% | 644.81% | 222.47% |